SCHEMBL6460693

SCHEMBL6460693

[c]1nccc(-c2ccccc2-c2c[nH]cn2)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27571250 0.72 DCUN1D1 (0.42)
SCHEMBL557782 0.70 IDO1 (0.43)
SCHEMBL558325 0.70 IDO1 (0.42)
SCHEMBL2650875 0.70 IDO1 (0.42)
SCHEMBL26259557 0.69 IKBKE (0.32)
SCHEMBL26259398 0.69 MEN1 (0.33)
SCHEMBL3859261 0.68 IDO1 (0.47)
SCHEMBL1501919 0.68 IDO1 (0.43)
SCHEMBL38658489 0.68 IDO1 (0.47)
SCHEMBL1501942 0.68 IDO1 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050203059-A1 Methods and compositions for treatment of ischemia HARRISON STEPHEN D (US) 2005-09-15 US disclosed
EP-1317433-A2 INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 CHIRON CORPORATION (US) 2003-06-11 EP disclosed
WO-2002020495-A2 INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 CHIRON CORPORATION (US) 2002-03-14 WO disclosed
EP-1087963-A1 INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 Chiron Corporation (US) 2001-04-04 EP disclosed
WO-1999065897-A1 INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 CHIRON CORPORATION (US) 1999-12-23 WO disclosed